grant

Tetramer Research and Development - immunologic and infectious diseases

Organization EMORY UNIVERSITYLocation ATLANTA, UNITED STATESPosted 21 Mar 2020Deadline 20 Mar 2027
NIHUS FederalResearch GrantFY2022Antigen Presentation PathwayAntigen Processing and PresentationAreaBar CodesBinding SitesBiotinClass II GenesCombining SiteCommunicable DiseasesCommunitiesContracting OpportunitiesContractsCore FacilityDNADeoxyribonucleic AcidDevelopment and ResearchDiseaseDisorderGolden HamstersGolden Syrian HamstersHLA Class II GenesImmuneImmunesImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsImmunologyInfectious Disease PathwayInfectious DiseasesInfectious DisorderMHC Class IIMHC Class II GenesMediatingMesocricetus auratusNational Institutes of HealthOligoOligonucleotidesPerformanceProductionR & DR&DReactive SiteReagentResearchResearch ResourcesResourcesStaining methodStainsStrepavidinStreptavidinSyrian HamstersT cell responseT-Cell ActivationT-CellsT-LymphocyteTechnologyTimeTumor CellUnited States National Institutes of HealthVariantVariationVitamin Hbarcodecoenzyme Rcostfluorophoremicrobe pathogenmicrobial pathogenneoplastic cellnoveloligospathogenic microberesearch and developmentthymus derived lymphocyte
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

The NIH Tetramer Core Facility provides valuable resources to the research community that enable cutting edge research in basic immunology and a wide variety of infectious disease areas via production and distribution of class I, class II and CD1 reagents. The reagents are being applied to studies of antigen processing and presentation, T cell activation, T cell responses against microbial pathogens or tumors, and T cell-mediated exacerbation or amelioration of immune-mediated diseases. This contract conducts research and development that would enhance the quality, functionality (e.g., sensitivity), and breadth of available tetramer reagents and decrease production time.

Grant Number: 75N93020D00005-0-759302200001-1
NIH Institute/Center: NIH
Principal Investigator: JOHN ALTMAN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →

Explore more

📍 More grants in UNITED STATES🏷 More NIH opportunities🏷 More US Federal opportunities🏷 More Research Grant opportunities🏢 All nih_reporter opportunities
Tetramer Research and Development - immunologic and infectious diseases — EMORY UNIVERSITY | UNITED STATES | Mar 2020 | Dev Procure